DEF 14A: Vicor Corporation Announces 2024 Annual Meeting of Stockholders, Director Nominees
Proxy Statement
Vicor Corporation will hold its 2024 Annual Meeting of Stockholders on June 21, 2024, to elect twelve directors and address other business matters.
Summary
- Vicor Corporation is holding its 2024 Annual Meeting of Stockholders on June 21, 2024, at 9:00 a.m. Eastern Time, at the offices of Foley & Lardner LLP in Boston.
- The primary purpose of the meeting is to fix the number of directors at twelve and elect the twelve nominees listed in the proxy statement to the Board of Directors, who will serve until the 2025 Annual Meeting.
- Stockholders of record as of April 26, 2024, are entitled to vote at the meeting.
- As of March 31, 2024, there were 32,800,034 shares of Common Stock and 11,743,218 shares of Class B Common Stock outstanding.
- Each share of Common Stock has one vote, and each share of Class B Common Stock has ten votes.
- Dr. Patrizio Vinciarelli, Chairman of the Board, President, and CEO, controls approximately 79.7% of the total voting power.
- The Board of Directors recommends voting FOR the election of all director nominees.
- The proxy statement, notice of the annual meeting, and proxy card were first mailed to stockholders on or about May 6, 2024.
- The Corporation's 2023 Annual Report on Form 10-K, including financial statements for the fiscal year ended December 31, 2023, will be mailed to Stockholders concurrently with this Proxy Statement.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, presenting routine matters for shareholder vote. The sentiment is neutral to slightly positive due to the recommendation of all nominees and the presence of independent directors on key committees.
Positives
- The Board of Directors is recommending a slate of twelve experienced nominees for election.
- The Corporation has a compensation recovery policy in place.
- The Corporation has an Audit Committee comprised of independent directors.
- The Corporation has a Compensation Committee comprised of independent directors.
Negatives
- The Corporation is a controlled company, meaning Dr. Vinciarelli holds more than 50% of the voting power, which reduces the need to comply with certain corporate governance requirements.
- The Board does not have a lead independent director.
Risks
- The Corporation's status as a controlled company could lead to less independent oversight.
- The absence of a lead independent director could concentrate power in the hands of the Chairman and CEO.
Future Outlook
The Corporation expects to continue the Agreement with Mr. DAmico, under the same terms and conditions, for the remainder of 2024.
Management Comments
- Dr. Vinciarelli has stated an intention to vote in favor of fixing the number of Directors at twelve and in favor of the election of all Nominees.
Industry Context
The document provides information on director elections, executive compensation, and corporate governance, which are standard disclosures for publicly traded companies.
Comparison to Industry Standards
- The board composition and committee structure are typical for companies listed on the NASDAQ.
- Executive compensation practices, including base salary, bonus, and stock options, are common in the semiconductor industry.
- The presence of a controlled company structure is not uncommon, but it does raise questions about independent oversight.
- The peer group used for TSR comparison is the Standard & Poor's SmallCap 600 Index (S&P SmallCap 600 Index), a value-weighted index of 600 listed companies with market capitalizations between $750,000,000 and $4,600,000,000.
Related Party Transactions
- Mr. DAmico, a Director and Nominee, serves as general counsel for intellectual property matters and receives compensation and reimbursement from the Corporation.
- The Corporation has a license agreement with IceMOS Technology Corporation, where Mr. Anderson, a Director and Nominee, is the Chairman of the Board, President, and Chief Executive Officer.
Stakeholder Impact
- Shareholders will vote on the election of directors and other corporate matters.
- Employees are affected by executive compensation policies and benefit plans.
- The Corporation's performance impacts stakeholders, including customers, suppliers, and creditors.
Next Steps
- Stockholders are requested to vote on the proposals outlined in the proxy statement.
- The Corporation will hold its Annual Meeting on June 21, 2024.
- The Board will continue to oversee the Corporation's strategy, operations, and risk management.
Key Dates
| Date | Description |
|---|---|
| March 31, 2024 | Date used for determining share ownership and voting power. |
| April 26, 2024 | Record date for determining stockholders entitled to vote at the Annual Meeting. |
| April 29, 2024 | Date of the letter to stockholders and information regarding nominees. |
| May 6, 2024 | Approximate date of mailing the Proxy Solicitation Materials to Stockholders. |
| June 21, 2024 | Date of the 2024 Annual Meeting of Stockholders. |
| January 6, 2025 | Deadline for receipt of stockholder proposals for inclusion in the 2025 proxy statement. |
| March 23, 2025 | Date after which the Board will have discretionary voting authority with respect to stockholder proposals. |
Keywords
Annual Meeting, Proxy Statement, Board of Directors, Director Election, Corporate Governance, Stockholders, Compensation, Vicor Corporation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.